|
Phase II clinical trial of recombinant human granulocyte colony-stimulating factor(fhG-CSF)(KRN8601) in advanced cancer patients with myelosuppression after chemotherapy
Jae Kyung Roh, Jin Hyuk Choi, Kyung Hee Lee, Hye Ran Lee, Nae Choon Yoo, Joo Hang Kim, Byung Soo Kim, Ho Young Lim
J Korean Cancer Assoc. 1993;25(5):725-735.
|